Abstract

BackgroundDiarrhoea is a major cause of childhood disease in the developing countries. This experimental study investigated the prevalence of ESBL and MBL genes in enteropathogenic strains of Escherichia coli and Salmonella spp. isolated from diarrheagenic children in Awka, Nigeria.MethodsTwo hundred stool samples were collected from diarrhea patients in three paediatric hospitals within Awka metropolis, Nigeria. All E. coli and Salmonella spp. isolated through standard bacteriological methods were subjected to antibiotic-susceptibility testing. Double disc synergy and imipenem-EDTA combined disc tests were used to phenotypically confirm the presence of ESBL and MBL respectively. PCR amplification of β-lactamase genes was done.ResultsThe prevalence of E. coli and Salmonella species in this study were 54% and 24.5% respectively. The organisms were highly resistant to metronidazole, cefuroxime and ceftazidime, and also showed a high sensitivity to nitrofurantoin and gentamicin. ESBL production was recorded in E. coli (49%) and Salmonella spp. (51.1%) while 27 isolates of E. coli (25%) and 7 isolates of Salmonella spp. were confirmed MBL positive by the combined disk diffusion technique. Eleven E. coli and 4 Salmonella spp. co-harbored both ESBL and MBL production. The most prevalent MBL gene in this study is the blaVIM gene (18.8%) which mediate MBL production in Gram negative bacteria; and this was followed by blaSHV (12.5%), blaTEM and blaCTX-M (6.3% each) for E. coli isolates. Salmonella spp. was recorded to have blaVIM (28.8%), blaSHV (28.8%), blaTEM (14.3%) and blaCTX-M (14.3%) genes.ConclusionsThis study reveals the prevalence of enteropathogenic E. coli and Salmonella strains bacteriologically recovered from diarrheic children in Awka, Nigeria, and which were found to be multiple resistant to clinically-relevant antibiotics because they co-express ESBL and MBL genes which mediate multidrug resistance in Gram negative bacteria.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call